Drug Shortage Report for MYLAN-BUDESONIDE AQ

Last updated on 2020-01-21 History
Report ID 23166
Drug Identification Number 02230648
Brand name MYLAN-BUDESONIDE AQ
Common or Proper name BUDESONIDE AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 100MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL
Packaging size 165
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-04-16
Actual start date 2018-04-16
Estimated end date 2020-01-30
Actual end date 2020-01-20
Shortage status Resolved
Updated date 2020-01-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v92 2018-06-25 French Compare
v91 2018-06-25 English Compare
v90 2018-06-12 French Compare
v89 2018-06-12 English Compare
v88 2018-06-12 English Compare
v87 2018-05-28 French Compare
v86 2018-05-28 English Compare
v85 2018-05-24 French Compare
v84 2018-05-24 English Compare
v83 2018-05-14 French Compare
v82 2018-05-14 English Compare
v81 2018-05-11 French Compare
v80 2018-05-11 English Compare
v79 2018-04-17 English Compare
v78 2018-04-16 French Compare
v77 2018-04-16 English Compare
v76 2018-04-13 French Compare
v75 2018-04-13 English Compare
v74 2018-04-11 French Compare
v73 2018-04-11 English Compare

Showing 41 to 60 of 132